Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?
- 15 December 2000
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 46 (2-3), 81-89
- https://doi.org/10.1016/s0920-9964(00)00025-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Abnormalities in the Distributed Network of Sustained Attention Predict Neuroleptic Treatment Response in SchizophreniaNeuropsychopharmacology, 1998
- A longitudinal analysis of eye tracking dysfunction and attention in recent‐onset schizophreniaPsychophysiology, 1998
- Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's diseaseBrain, 1998
- Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open studyActa Psychiatrica Scandinavica, 1997
- Abnormalities of tracking behavior in Parkinson's diseaseMovement Disorders, 1995
- Distributed motor processing in cerebral cortexCurrent Opinion in Neurobiology, 1994
- Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's diseaseBrain, 1993
- Alternating fluency in Parkinson's diseaseBrain, 1993
- Set-shifting and spatial orientation in patients with Parkinson's diseaseJournal of Clinical and Experimental Neuropsychology, 1992
- The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic PatientsThe Journal of Clinical Pharmacology, 1987